| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |